The regulatory effects of nicotine in the brain (ie, tobacco smoking-induced upregulation of β(2)*-nAChRs) seem to be distinctly different between men and women, and female sex steroid hormones likely have a role in this regulation. These findings suggest an underlying neurochemical mechanism for the reported behavioral sex differences. To treat female smokers more effectively, it is critical that nonnicotinic-mediated medications should be explored.
No takes yet. Share an insight, caveat, or question.
Kelly Cosgrove (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: